Clinical Observation of Treating Ulcerative Colitis with Acupuncture at Front Mu Points Combined with Oral Mesalazine

Chunling LI; Linghua LI; Xu HAN; Jie YANG; Heng ZHANG

doi:10.12259/j.issn.2095-610X.S20240311

Volume 45 Issue 3

Mar. 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2024 > 45(3): 72-78

Chunling LI, Linghua LI, Xu HAN, Jie YANG, Heng ZHANG. Clinical Observation of Treating Ulcerative Colitis with Acupuncture at Front Mu Points Combined with Oral Mesalazine[J]. Journal of Kunming Medical University, 2024, 45(3): 72-78. doi: 10.12259/j.issn.2095-610X.S20240311

Citation:

Chunling LI, Linghua LI, Xu HAN, Jie YANG, Heng ZHANG. Clinical Observation of Treating Ulcerative Colitis with Acupuncture at Front Mu Points Combined with Oral Mesalazine[J]. Journal of Kunming Medical University, 2024, 45(3): 72-78. doi: 10.12259/j.issn.2095-610X.S20240311

Citation:

Chunling LI, Linghua LI, Xu HAN, Jie YANG, Heng ZHANG. Clinical Observation of Treating Ulcerative Colitis with Acupuncture at Front Mu Points Combined with Oral Mesalazine[J]. Journal of Kunming Medical University, 2024, 45(3): 72-78. doi: 10.12259/j.issn.2095-610X.S20240311

PDF( 4036 KB)

Clinical Observation of Treating Ulcerative Colitis with Acupuncture at Front Mu Points Combined with Oral Mesalazine

doi: 10.12259/j.issn.2095-610X.S20240311

1.
Dept. of Anorectal，Kunming Municipal Hospital of Traditional Chinese Medicine， Kunming Yunnan 650500，China

Received Date: 2023-11-01
Available Online: 2024-03-21
Publish Date: 2024-03-30

Abstract

Abstract

Objective To observe the clinical efficacy of acupuncture at Front Mu point in the treatment of ulcerative colitis. Methods Sixty patients with ulcerative colitis treated at the Traditional Chinese Medicine Hospital in Kunming from August 2022 to June 2023 were collected. Using a random number table method, 30 cases were assigned to each of the control group and the combined group. The treatment method involved administering oral mesalazine to the control group for a continuous period of 8 weeks, while the combined group received both oral mesalazine and acupuncture at front Mu points. The clinical efficacy, colonoscopy results score （Baron score）, and colonic mucosal healing score （Geboes） before and after treatment were compared. Follow-up was conducted at 3 months to calculate the recurrence rate in the combination and control groups. Results The total effective rate in the combination group was higher than that in the control group （P < 0.05）, with rates of 93.33% and 67.67%, respectively. After treatment, the disease activity index, Baron score, and Geboes score decreased compared to before treatment （P < 0.05）, and the combination group had a lower disease activity index, Baron score, and Geboes score than the control group after treatment （P < 0.05）. Comparing the recurrence rates at 3 months post-treatment, the combination group was lower than the control group. Conclusion Acupuncture at Front Mu Point can significantly improve the clinical symptoms of ulcerative colitis, reduce the recurrence rate compared to patients in the control group, and is safe and reliable without serious adverse reactions.
- Ulcerative colitis,
- Mesalazine,
- Front Mu point,
- Clinical efficacy,
- Recurrence rate

FullText(HTML)

References(31)

References

[1]	Warren S,Sommers S C. Pathogenesis of ulcerative colitis[J]. The American Journal of Pathology,1949,25(4):657-679.
[2]	Jewell D P, Sutherland L R, McDonald J W D, et al. Ulcerative colitis[J]. Evidence‐based Gastroenterology and Hepatology, 2010, 12: 232-247.
[3]	Gajendran M,Loganathan P,Jimenez G,et al. A comprehensive review and update on ulcerative colitis[J]. Disease-a-month,2019,65(12):100851. doi: 10.1016/j.disamonth.2019.02.004
[4]	Rashid N S Lui, Siew C Ng. The same intestinal inflammatory disease despite different genetic risk factors in the East and West?[J]. Inflammatory Intestinal Diseases,2016,1(2):78-84. doi: 10.1159/000446625
[5]	Kamm M A,Lichtenstein G R,Sandborn W J,et al. Randomised trial of once-or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis[J]. Gut,2008,57(7):893-902. doi: 10.1136/gut.2007.138248
[6]	Ham M,Moss A C. Mesalamine in the treatment and maintenance of remission of ulcerative colitis[J]. Expert Review of Clinical Pharmacology,2012,5(2):113-123. doi: 10.1586/ecp.12.2
[7]	Li R,Huang X,Yang L,et al. Integrated analysis reveals the targets and mechanisms in immunosuppressive effect of mesalazine on ulcerative colitis[J]. Frontiers in Nutrition,2022,9:867692. doi: 10.3389/fnut.2022.867692
[8]	Sehgal P,Colombel J F,Aboubakr A,et al. Systematic review: safety of mesalazine in ulcerative colitis[J]. Alimentary Pharmacology & Therapeutics,2018,47(12):1597-1609.
[9]	李星霞,孙习鹏,陈燕,等. 临床药师参与美沙拉秦引起心脏毒性的药物治疗 1 例[J]. 临床药物治疗杂志,2020,18(6):78-81. doi: 10.3969/j.issn.1672-3384.2020.06.015
[10]	Joos S,Wildau N,Kohnen R,et al. Acupuncture and moxibustion in the treatment of ulcerative colitis: a randomized controlled study[J]. Scandinavian Journal of Gastroenterology,2006,41(9):1056-1063. doi: 10.1080/00365520600580688
[11]	Wang X,Zhao N,Sun Y,et al. Acupuncture for ulcerative colitis: A systematic review and meta-analysis of randomized clinical trials[J]. BMC Complementary Medicine and Therapies,2020,20:1-10. doi: 10.1186/s12906-019-2780-5
[12]	Cabioglu M T,Kaya Y,Surucu H S. Neurophysiologic basis of front-Mu points[J]. Neuroanatomy,2009,8:32-35.
[13]	Chen Y,Zhao Y,Tan R Y S,et al. The influence of stomach back-shu and front-mu points on insular functional connectivity in functional dyspepsia rat models[J]. Evidence-based Complementary and Alternative Medicine: eCAM,2021,2021:2771094.
[14]	李军祥,陈誩. 溃疡性结肠炎中西医结合诊疗共识意见2017年)[J]. 中国中西医结合消化杂志,2018,26(2):105-120.
[15]	郑筱萸. 中药新药临床研究指导原则（试行）[S]. 北京: 中国医药科技出版社, 2002, 72: 151-156.
[16]	何建伟,丁益宏,韩晓梅,等. 愈疡合剂直肠滴注疗法对溃疡性结肠炎大肠湿热型患者中医证候、血清IL-6、IL-10、TNF-α 水平的影响[J]. 四川中医,2021,39(10):98-101.
[17]	孟梦,周强,朱春洋,等. 张声生教授辨治溃疡性结肠炎中医临证经验[J]. 世界中医药,2022,17(6):838-842.
[18]	Zheng S,Xue T,Wang B,et al. Chinese medicine in the treatment of ulcerative colitis: The mechanisms of signaling pathway regulations[J]. The American Journal of Chinese Medicine,2022,50(7):1781-1798. doi: 10.1142/S0192415X22500756
[19]	Li G G,Bai G,Jiao Z. Correlation between traditional Chinese medicine (TCM) syndromes of ulcerative colitis and enteroscope[J]. Chinese Archives of Traditional Chinese Medicine,2022,40(2):90-93.
[20]	Kucharzik T,Koletzko S,Kannengiesser K,et al. Ulcerative colitis-diagnostic and therapeutic algorithms[J]. Deutsches Ä rzteblatt International,2020,117(33-34):564-574.
[21]	Karagozian R,Burakoff R. The role of mesalamine in the treatment of ulcerative colitis[J]. Therapeutics and Clinical Risk Management,2007,3(5):893-903.
[22]	Sicilia B,García-López S,González-Lama Y,et al. GETECCU 2020 guidelines for the treatment of ulcerative colitis. Developed using the GRADE approach[J]. Gastroenterologia y hepatologia,2020,43:1-57.
[23]	Burri E,Maillard M H,Schoepfer A M,et al. Treatment algorithm for mild and moderate-to-severe ulcerative colitis: an update[J]. Digestion,2020,13(25):2-15.
[24]	贾文睿,苏晓兰,甄建华,等. 近20年针灸治疗溃疡性结肠炎研究进展[J]. 针灸临床杂志,2020,36(5):99-103.
[25]	Song G,Fiocchi C,Achkar J P. Acupuncture in inflammatory bowel disease[J]. Inflammatory Bowel Diseases,2019,25(7):1129-1139. doi: 10.1093/ibd/izy371
[26]	Bao C,Wu L,Wang D,et al. Acupuncture improves the symptoms,intestinal microbiota,and inflammation of patients with mild to moderate Crohn’s disease: A randomized controlled trial[J]. E Clinical Medicine,2022,45:101300. doi: 10.1016/j.eclinm.2022.101300
[27]	毕婷婷. 针灸治疗溃疡性结肠炎的临床研究进展[J]. 中国民间疗法,2019,27(23):106.
[28]	纪丽, 高宗跃. 针刺合中药保留灌肠联合西药治疗溃疡性结肠炎的疗效及对炎症因子水平、肠黏膜屏障指标的影响[ J] . 中医研究, 2022, 35（11）: 29-33.
[29]	薛丹,蔡敬宙,韩棉梅,等. 俞募配穴温针灸疗法在治疗溃疡性结肠炎中的应用[J]. 广东医学,2018,39(15):2377-2380.
[30]	李皓月,梁浩. 电针天枢穴对溃疡性结肠炎大鼠 TLR4/NF-κB 信号通路的影响[J]. 新中医,2018,50(12):20-24.
[31]	Yan J,Zhang H,Chen C T,et al. Effects of electroacupuncture at Shangjuxu (ST 37) on interleukin-1beta and interleukin-4 in the ulcerative colitis model rats[J]. Journal of Traditional Chinese Medicine,2009,29(1):60-63. doi: 10.1016/S0254-6272(09)60033-9

Relative Articles(20)

Relative Articles

[1]	Hanyu ZHANG, Juan LUO, Mingzhi DONG, Qiyin CHEN, Fengrui ZHANG, Rui GUO, Junying TONG, Yinglei MIAO. Retrospective Cohort Study of Infliximab and Vederizumab in the Treatment of Moderate-to-severe Ulcerative Colitis. Journal of Kunming Medical University, 2025, 46(4): 1-9.
[2]	Liyuan YUN, Junfeng WANG, Ning GUO, Ruimei DING, Haipeng LI, Xueping ZHANG. Analysis of the Efficacy and Safety of GM1 Injection Combined with Batroxobin in the Treatment of Sudden Deafness Patients. Journal of Kunming Medical University, 2024, 45(6): 140-144. doi: 10.12259/j.issn.2095-610X.S20240619
[3]	Fen TENG, Bo TIAN, Chongxi LI, Yongmei JIN, Haiyun CHEN, Jun LIU. Real-World Clinical Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide （BIC/FTC/TAF） Single-Tablet Regimen. Journal of Kunming Medical University, 2024, 45(4): 74-80. doi: 10.12259/j.issn.2095-610X.S20240411
[4]	Hanyu ZHANG, Juan LUO, Mingzhi DONG, Qiyin CHEN, Fengrui ZHANG, Rui GUO, Junying TONG, Yinglei MIAO. Retrospective Cohort Study of Infliximab and Vederizumab in the Treatment of Moderate-to-severe Ulcerative Colitis. Journal of Kunming Medical University, 2024, 45(10): 36-44. doi: 10.12259/j.issn.2095-610X.S20241006
[5]	Meizi RAO, Xinyi JIANG, Jiarong MIAO. Analysis of Risk Factors for Co-Infection of Ulcerative Colitis with Epstein-barr Virus and Cytomegalovirus. Journal of Kunming Medical University, 2024, 45(11): 87-94. doi: 10.12259/j.issn.2095-610X.S20241113
[6]	Xiaohua LU, Hongxin YUAN. The Analysis of the Correlation between BTLA，CTLA-4 Gene Polymorphisms and the Efficacy and Prognosis of TACE Combined Targeted Therapy for Liver Cancer. Journal of Kunming Medical University, 2023, 44(9): 126-135. doi: 10.12259/j.issn.2095-610X.S20230927
[7]	Rui CUN, Meiling CHEN. Efficacy and Clinical Application of Flunarizine Combined with Ginkgo damo in Treatment of Senile Vertigo. Journal of Kunming Medical University, 2022, 43(7): 116-120. doi: 10.12259/j.issn.2095-610X.S20220703
[8]	Xiaolin LIU, Xiaocui CHEN, Yang SUN, Minli LI, Yinglei MIAO. Clinical Efficacy and Safety Evaluation of Fecal Bacteria Transplantation by Different Ways on Ulcerative Colitis. Journal of Kunming Medical University, 2022, 43(6): 46-51. doi: 10.12259/j.issn.2095-610X.S20220612
[9]	Pan Zi Peng . Analysis and Safety Evaluation of the Clinical Efficacy of Laparoscopic Appendectomy for Acute Appendicitis. Journal of Kunming Medical University,
[10]	Hu Wei Hua . The Observation of Clinical Effect of Using Ambroxol in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Journal of Kunming Medical University,
[11]	Zhao Li Dong . Clincal Effect of Different Doses of Esomeprazole in Treatment of Acute Nonvariceal Upper Gastrointestinal Bleeding. Journal of Kunming Medical University,
[12]	Chen Xiao Hong . Influence of Continuous Nursing Intervention on Psychological Quality and Medication Compliance in Ulcerative Colitis Patients after Discharge. Journal of Kunming Medical University,
[13]	Shang Xue Qin . . Journal of Kunming Medical University,
[14]	Zeng Hai Ping . . Journal of Kunming Medical University,
[15]	Ai Jia . . Journal of Kunming Medical University,
[16]	Li Hong Li . . Journal of Kunming Medical University,
[17]	Hu Hai Yan . . Journal of Kunming Medical University,
[18]	Liu Yue Bo . . Journal of Kunming Medical University,
[19]	. . Journal of Kunming Medical University,
[20]	Yang Xi Yun . . Journal of Kunming Medical University,